Quest Diagnostics to add ctDNA detection technology with Haystack Oncology
Quest Diagnostics, an American diagnostic information services provider, has agreed to acquire early-stage oncology company Haystack Oncology in an all-cash deal worth up to $450 million in a move to add sensitive liquid biopsy technology for enhancing personalized cancer care to its oncology portfolio. Based in Baltimore, Maryland, Haystack Oncology is focused on minimal residual […]